Showing 8,801 - 8,820 results of 17,722 for search '(( 50 ((((mg decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 5 ng decrease ))', query time: 0.86s Refine Results
  1. 8801

    Photothermal therapy co-localized with CD137 agonism improves survival in an SM1 melanoma model without hepatotoxicity by Jacob A Medina (19530945)

    Published 2024
    “…<i>In vivo</i>, SM1 tumor-bearing mice treated with αCD137-PBNP-PTT exhibited a significantly higher survival rate (50%) without hepatotoxicity, compared with control treatments.…”
  2. 8802

    DataSheet1_Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study.docx by Maoxing Zhong (18601849)

    Published 2024
    “…In this research, we examined the changes in abnormal brain regions among FES patients undergoing long-term treatment using a dynamic perspective. A total of 98 participants were included in the data analysis, comprising 48 FES patients, 50 healthy controls, 22 patients completed a follow-up period of more than 6 months with qualified data. …”
  3. 8803

    <b>Data from:The Correlation Between Blue Carbon Storage and Landscape Fragmentation: A Micro-Scale Perspective on Two Decades of Coastal Wetland Change in China</b> by Er Yu (22753181)

    Published 2025
    “…Total carbon storage declined from 62.68 Tg to 50.41 Tg, with natural wetlands showing an initial decrease followed by a partial recovery. …”
  4. 8804
  5. 8805
  6. 8806
  7. 8807
  8. 8808
  9. 8809
  10. 8810

    Table_1_Physical Activity Behavior During and After COVID-19 Stay-at-Home Orders—A Longitudinal Study in the Austrian, German, and Italian Alps.DOCX by Stefanie E. Schöttl (12692858)

    Published 2022
    “…A larger percentage of participants from Alpine regions with severe restrictions (Tyrol, South Tyrol, Trentino) decreased their PA during the first lockdown as compared to participants from Upper Bavaria and Vorarlberg with a less strict first lockdown. …”
  11. 8811

    DataSheet1_Moisture Stability of Sulfide Solid-State Electrolytes.docx by Thomas A. Yersak (12516721)

    Published 2022
    “…We find that moisture stability improves with 75 mol% Li<sub>2</sub>S modifier content and the introduction of a Li<sub>2</sub>O co-modifier. After a 30 min exposure in a −40°C dewpoint dry room environment we found that (Li<sub>2</sub>S)<sub>75</sub>(P<sub>2</sub>S<sub>5</sub>)<sub>25</sub> + 20 mol% LiI powder generated 0.1 cc/g H<sub>2</sub>S and its ionic conductivity decreased by over 50%. …”
  12. 8812

    Presentation 1_Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study.pdf by Meiling Zhang (352540)

    Published 2024
    “…The most common adverse events included hand-foot syndrome (54.5%), asthenia (50.0%), decreased white blood cell count (45.5%), and liver impairment (45.5%). …”
  13. 8813
  14. 8814

    DataSheet_1_Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up study.docx by Daidi Zhao (5179145)

    Published 2023
    “…</p>Results<p>Of 108 patients, 80 (74.1%) initiated low-dose RTX therapy immediately after acute attack treatment and 33 (30.6%) initiated it after the first attack. During a median treatment period of 35.5 (22.0–48.8) months, significant decreases were observed in median ARR (1.1 [0.8–2.0] versus 0 [0–0.2], p < 0.001), EDSS score (3.5 [2.5–4.0] versus 2.0 [1.0–3.0], p < 0.001) and spinal cord lesion segments (5.0 [4.0–8.0] versus 3.0 [1.0–6.0], p < 0.001). …”
  15. 8815

    Data_Sheet_1_Magnetic Resonance Spectroscopy in the Ventral Tegmental Area Distinguishes Responders to Suvorexant Prior to Treatment: A 4-Week Prospective Cohort Study.pdf by Muneto Izuhara (11312766)

    Published 2021
    “…The present study examined the utility of magnetic resonance spectroscopy (MRS) for detecting neural and/or glial changes in the VTA to distinguish responders from non-responders before treatment with the orexin receptor antagonist suvorexant.</p><p>Methods: A total of 50 patients were screened and 9 patients were excluded. …”
  16. 8816

    Table_1_Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model.DOCX by Zijuan Zhang (1343181)

    Published 2022
    “…<p>Parkinson’s disease (PD) is a chronic neurodegenerative disease. Type 2 diabetes mellitus (T2DM) has been identified as a risk factor for PD. …”
  17. 8817

    DataSheet1_A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia... by Kornvipa Settakorn (17840342)

    Published 2024
    “…Twenty−seven TDT patients were randomly divided into placebo and GTE tablet (50 and 100 mg EGCG equivalent) groups and assigned to consume the product once daily for 60 days. …”
  18. 8818

    DataSheet2_A randomized placebo−controlled clinical trial of oral green tea epigallocatechin 3−gallate on erythropoiesis and oxidative stress in transfusion−dependent β−thalassemia... by Kornvipa Settakorn (17840342)

    Published 2024
    “…Twenty−seven TDT patients were randomly divided into placebo and GTE tablet (50 and 100 mg EGCG equivalent) groups and assigned to consume the product once daily for 60 days. …”
  19. 8819
  20. 8820